DENIS CHEM LAB
|
|
BOM : 537536     NSE :      | |
LT :  
    Long Term Analysis
Fundamentals : Bad
Valuation : Good [Stock is Cheap] Debt : Average |
Updated: |
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Neutral
Price Momentum : Downward Pledged Shares : NA |
Jun 29,2022 |
Price(EOD): ₹ 56.35
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
|
Pharmaceuticals & Drugs |
MCap: ₹ 78.33 Cr |
Industry Peers & Returns | 1W | 1M | 1Y |
DENIS CHEM LAB | 8.6% | -17% | 1.4% |
SUN PHARMACEUTICAL INDUSTRIES | 1.6% | -2.6% | 23.2% |
DIVIS LABORATORIES | -2.2% | -0.2% | -14.5% |
DR REDDYS LABORATORIES | 1.6% | -0.1% | -17.5% |
CIPLA | 1.4% | -4.9% | -1.2% |
GLAND PHARMA | 1.7% | -7.3% | -17.1% |
PIRAMAL ENTERPRISES | 2.1% | -12.2% | -30.3% |
CADILA HEALTHCARE | 2.9% | -5.9% | -42.7% |
TORRENT PHARMACEUTICALS | -0.5% | -0.3% | -0.1% |
FUNDAMENTAL ANALYSIS OF DENIS CHEM LAB
 Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
VALUATION OF DENIS CHEM LAB
 Ratio | Standalone | |
---|---|---|
P/E P/B P/S |
34.57
P/E Calculated based on EPS of 1.63
[ Mar2021 - Standalone Results ] 1.27
P/B Calculated based on Book Value of 44.32
[ Mar2021 - Standalone Results ] 0.57
P/S Calculated based on Revenues of 136.557 Cr
[ TTM - Standalone Results ] |
|
Financial Ratios → |
Model | Discount(-)/ Premium(+) |
---|---|
EV/EBIDTA EV/Sales Price/Sales |
-50% -48% -43% |
SHARE PRICE MOMENTUM OF DENIS CHEM LAB
DENIS CHEM LAB vs SENSEX
DEBT OF DENIS CHEM LAB
Year | Debt/Equity ratio | |
---|---|---|
Standalone | Consolidated | |
2021 2020 2019 Avg_3yrs |
0.16 0.23 0.4 0.26 |
- - - - |
[Last Annual Data : Mar2021]
|
||
Financial Ratios → |
PLEDGED PROMOTER SHARES OF DENIS CHEM LAB
Pledged Promoter Shares |
NA | |
---|---|---|
If less than 25% | Good |
|
If between 25% and 50% | Neutral | |
If greater than 50% | Bad | |
Shareholding Pattern → |
QTRLY RESULTS OF DENIS CHEM LAB
Standalone | Q-o-Q | Y-o-Y |
---|---|---|
Revenue Op Profit Profit Before Tax Profit After Tax |
11.55% -36.08% -12.67% -21.71% |
36.28% 56.77% 428.88% 426.74% |
QtrlyTrend |
2 | |
Latest Qtr: Mar2022 | ||
Quarterly Result Analysis → |
DENIS CHEM LAB related INDICES
You may also like the below Video Courses
FAQ about DENIS CHEM LAB
Is DENIS CHEM LAB good for long term investment?
As on Jun 29,2022, the Fundamentals of DENIS CHEM LAB look Poor and hence it may not be good for long term investment ! See Financial Performance of DENIS CHEM LAB . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!Is DENIS CHEM LAB UnderValued or OverValued?
As on Jun 29,2022, DENIS CHEM LAB is Under Valued based on the estimates of intrinsic value and hence may be a good buying opportunity according to Share Valuation at this time!What is the Intrinsic Value of DENIS CHEM LAB ?
As on Jun 29,2022, the Intrinsic Value of DENIS CHEM LAB is Rs. 108.58 determined based on Median of the 3 historical models.Fair Value [Median EV / EBIDTA Model] : Rs. 112.46
Fair Value [Median EV / Sales Model] : Rs. 108.58
Fair Value [Median Price / Sales Model] : Rs. 98.49
Median Fair Value of DENIS CHEM LAB : Rs. 108.58
Is DENIS CHEM LAB trading at a Premium or Discount?
As on Jun 29,2022, DENIS CHEM LAB is trading at a Discount of -48% based on the estimates of Median Intrinsic Value!SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs DR REDDYS LABORATORIES LTD
CIPLA LTD vs GLAND PHARMA LTD vs PIRAMAL ENTERPRISES LTD
CADILA HEALTHCARE LTD vs TORRENT PHARMACEUTICALS LTD vs ALKEM LABORATORIES LTD
LUPIN LTD vs AUROBINDO PHARMA LTD vs BIOCON LTD
ABBOTT INDIA LTD vs LAURUS LABS LTD vs IPCA LABORATORIES LTD
